The funding by Save the Children’s impact investing arm will allow PrimaKu to expand the customer base for its digital platform, which improves child healthcare outcomes.
The loan will enable the Wagagai farm, recently acquired by Selecta one, to develop its business and maintain its role as a hub for social initiatives.
The fund will invest in early-stage healthtech startups. It plans to bring scale through its partnerships with a variety of different health organisations around the world.
The European Investment Bank and the European Commission have joined forces with immunotherapy company BioNTech to advance a mRNA vaccine manufacturing facility in Rwanda.
Aerska develops RNA medicines for the treatment of neurological diseases such as Parkinson’s and Alzheimer’s, which affect millions of people worldwide.
The funding will enable the company to scale and commercialise its cloud-linked device, which allows medical professionals to remotely monitor key patient indicators such as heart rate, respiratory rate, and oxygen saturation.
Genoskin has developed a tool that can test pharmaceutical, cosmetic and chemical products on real human skin, offering an alternative to animal testing.